Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt

The use of cell-delivered gene therapy for the treatment of HIV/AIDS

(2010) Geoff P. Symonds et al.   IMMUNOLOGIC RESEARCH

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs

(2010) Christoph C Carter et al.   NATURE MEDICINE

RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

(2010) D. L. DiGiusto et al.   Science Translational Medicine

Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV

(2009) John M. Murray et al.   JOURNAL OF GENE MEDICINE

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

(2009) Ronald T Mitsuyasu et al.   NATURE MEDICINE

Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides

(2008) R C Zahn et al.   GENE THERAPY

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

(2008) David I Watkins et al.   NATURE MEDICINE

The Challenge of HIV-1 Subtype Diversity

(2008) Barbara S. Taylor et al.   NEW ENGLAND JOURNAL OF MEDICINE

Foamy Virus Vectors Expressing Anti-HIV Transgenes Efficiently Block HIV-1 Replication

(2007) Jason A Taylor et al.   MOLECULAR THERAPY